Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report.

Cafolla A, Gentile G, et al.

Department of Cellular Biotechnologies and Hematology Thrombosis Centre Sapienza University of Rome Rome Italy.

Clinical case reports. Mar 2017.

The treatment with fondaparinux is the effective and safe anticoagulant therapy in liver transplant patient on immunosuppressive therapy with arterial thrombosis, and it seems able to reduce liver fibrosis. Although this treatment is not generalizable, further prospective large studies need to confirm this case report.

Pubmed

Leave a Reply

Your email address will not be published. Required fields are marked *